Peru

Spravato is registered in Peru: registro sanitario EE08798 (J&J, 28 mg nasal spray, for treatment-resistant depression), currently commercialized — access via private psychiatry. But according to Digemid, the registry expired on 29-07-2025.

Racemic ketamine is registered and listed only as a hospital anesthetic (national essential-medicines list) — no registered psychiatric indication and no documented clinic market; any private offer deserves extra scrutiny.

No medical framework; traditional plant contexts are a separate legal category from psilocybin therapy.

No medical framework. Possession of small personal amounts falls under Penal Code art. 299’s non-punishability rules (void if carrying two or more drug types).

Medical cannabis legal by prescription: Law 30681 (Nov 2017), current reglamento DS 004-2023-SA; implementation limited. Possession of cannabis and its derivatives for medicinal and therapeutic purposes is not punishable (Penal Code art. 299): the amount is determined by the patient’s needs.

Thin formal-trial scene; most research on traditional use is observational/ethnobotanical. Participation is free; screening is strict; never pay for “trial access”.